1887

Abstract

Laboratory animal models have provided valuable insight into foot-and-mouth disease virus (FMDV) pathogenesis in epidemiologically important target species. While not perfect, these models have delivered an accelerated time frame to characterize the immune responses in natural hosts and a platform to evaluate therapeutics and vaccine candidates at a reduced cost. Further expansion of these models in mice has allowed access to genetic mutations not available for target species, providing a powerful and versatile experimental system to interrogate the immune response to FMDV and to target more expensive studies in natural hosts. The purpose of this review is to describe commonly used FMDV infection models in laboratory animals and to cite examples of when these models have failed or successfully provided insight relevant for target species, with an emphasis on natural and vaccine-induced immunity.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.068270-0
2014-11-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/95/11/2329.html?itemId=/content/journal/jgv/10.1099/vir.0.068270-0&mimeType=html&fmt=ahah

References

  1. Abu Elzein E. M., Crowther J. R. 1981; Detection and quantification of IgM, IgA, IgG1 and IgG2 antibodies against foot-and-mouth disease virus from bovine sera using an enzyme-linked immunosorbent assay. J Hyg (Lond) 86:79–85 [View Article][PubMed]
    [Google Scholar]
  2. Akira S. 1999; Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17:138–146 [View Article][PubMed]
    [Google Scholar]
  3. Alexandersen S., Mowat N. 2005; Foot-and-mouth disease: host range and pathogenesis. Curr Top Microbiol Immunol 288:9–42[PubMed]
    [Google Scholar]
  4. Alexandersen S., Zhang Z., Donaldson A. I., Garland A. J. M. 2003; The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol 129:1–36 [View Article][PubMed]
    [Google Scholar]
  5. Aramburu H. G. 1949; A comparison of different methods of inoculating guinea-pigs with the virus of foot-and-mouth disease. J Comp Pathol Ther 59:42–47 [View Article][PubMed]
    [Google Scholar]
  6. Arkwright J. A., Burbury M. 1925; Observations on foot-and-mouth disease. Section I. Transmission of foot-and-mouth disease to rodents. J Comp Pathol Ther 38:231–238 [CrossRef]
    [Google Scholar]
  7. Arzt J., Baxt B., Grubman M. J., Jackson T., Juleff N., Rhyan J., Rieder E., Waters R., Rodriguez L. L. 2011a; The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions. Transbound Emerg Dis 58:305–326 [View Article][PubMed]
    [Google Scholar]
  8. Arzt J., Juleff N., Zhang Z., Rodriguez L. L. 2011b; The pathogenesis of foot-and-mouth disease I: viral pathways in cattle. Transbound Emerg Dis 58:291–304 [View Article][PubMed]
    [Google Scholar]
  9. Arzt J., Pacheco J. M., Smoliga G. R., Tucker M. T., Bishop E., Pauszek S. J., Hartwig E. J., de los Santos T., Rodriguez L. L. 2014; Foot-and-mouth disease virus virulence in cattle is co-determined by viral replication dynamics and route of infection. Virology 452–453:12–22 [View Article][PubMed]
    [Google Scholar]
  10. Bachrach H. L. 1968; Foot-and-mouth disease. Annu Rev Microbiol 22:201–244 [View Article][PubMed]
    [Google Scholar]
  11. Barasa M., Catley A., Machuchu D., Laqua H., Puot E., Tap Kot D., Ikiror D. 2008; Foot-and-mouth disease vaccination in South Sudan: benefit-cost analysis and livelihoods impact. Transbound Emerg Dis 55:339–351 [View Article][PubMed]
    [Google Scholar]
  12. Barnard A. L., Arriens A., Cox S., Barnett P., Kristensen B., Summerfield A., McCullough K. C. 2005; Immune response characteristics following emergency vaccination of pigs against foot-and-mouth disease. Vaccine 23:1037–1047 [View Article][PubMed]
    [Google Scholar]
  13. Barnett P. V., Carabin H. 2002; A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine 20:1505–1514 [View Article][PubMed]
    [Google Scholar]
  14. Batista A., Quattrocchi V., Olivera V., Langellotti C., Pappalardo J. S., Di Giacomo S., Mongini C., Portuondo D., Zamorano P. 2010; Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice. Vaccine 28:6361–6366 [View Article][PubMed]
    [Google Scholar]
  15. Bautista E. M., Ferman G. S., Golde W. T. 2003; Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet Immunol Immunopathol 92:61–73 [View Article][PubMed]
    [Google Scholar]
  16. Baxt B., Vakharia V., Moore D. M., Franke A. J., Morgan D. O. 1989; Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol 63:2143–2151[PubMed]
    [Google Scholar]
  17. Beattie J. M., Morcos Z., Peden D. 1928; Transmission of foot-and-mouth disease in rodents by contact: II. The spread of foot-and-mouth disease by rats, rabbits, and birds. J Comp Pathol Ther 41:353–362 [View Article]
    [Google Scholar]
  18. Bedson S. P., Maitland H. B., Burbury Y. M. 1927; Further observations on foot-and-mouth disease. J Comp Pathol Ther 40:5–36 [View Article]
    [Google Scholar]
  19. Berinstein A., Piatti P., Gaggino O. P., Schudel A. A., Sadir A. M. 1991; Enhancement of the immune response elicited with foot-and-mouth disease virus vaccines by an extract of the Mycobacterium sp. wall. Vaccine 9:883–888 [View Article][PubMed]
    [Google Scholar]
  20. Berinstein A., Pérez Filgueira M., Schudel A., Zamorano P., Borca M., Sadir A. 1993; Avridine and LPS from Brucella ovis: effect on the memory induced by foot-and-mouth disease virus vaccination in mice. Vaccine 11:1295–1301 [View Article][PubMed]
    [Google Scholar]
  21. Berkowitz A., Waner T., King R., Yadin H., Perl S. 2010; Description of the pathology of a gazelle that died during a major outbreak of foot-and-mouth disease in Israel. J S Afr Vet Assoc 81:62–64 [View Article][PubMed]
    [Google Scholar]
  22. Borca M. V., Fernández F. M., Sadir A. M., Schudel A. A. 1984; Reconstitution of immunosuppressed mice with mononuclear cells from donors sensitized to foot-and-mouth disease virus (FMDV). Vet Microbiol 10:1–11 [View Article][PubMed]
    [Google Scholar]
  23. Borca M. V., Fernández F. M., Sadir A. M., Braun M., Schudel A. A. 1986; Immune response to foot-and-mouth disease virus in a murine experimental model: effective thymus-independent primary and secondary reaction. Immunology 59:261–267[PubMed]
    [Google Scholar]
  24. Brown F. 1992; New approaches to vaccination against foot-and-mouth disease. Vaccine 10:1022–1026 [View Article][PubMed]
    [Google Scholar]
  25. Brown F. 2001; Inactivation of viruses by aziridines. Vaccine 20:322–327 [View Article][PubMed]
    [Google Scholar]
  26. Brown F. 2003; The history of research in foot-and-mouth disease. Virus Res 91:3–7 [View Article][PubMed]
    [Google Scholar]
  27. Campbell C. H. 1970; Adsorption of foot-and-mouth disease virus by muscle, kidney, lung and brain from infant and adult mice. Can J Comp Med 34:279–284[PubMed]
    [Google Scholar]
  28. Carr B. V., Lefevre E. A., Windsor M. A., Inghese C., Gubbins S., Prentice H., Juleff N. D., Charleston B. 2013; CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle. J Gen Virol 94:97–107 [View Article][PubMed]
    [Google Scholar]
  29. Cartwright B., Morrell D. J., Brown F. 1982; Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1. J Gen Virol 63:375–381 [View Article][PubMed]
    [Google Scholar]
  30. Catley A., Chibunda R. T., Ranga E., Makungu S., Magayane F. T., Magoma G., Madege M. J., Vosloo W. 2004; Participatory diagnosis of a heat-intolerance syndrome in cattle in Tanzania and association with foot-and-mouth disease. Prev Vet Med 65:17–30 [View Article][PubMed]
    [Google Scholar]
  31. Charleston B., Bankowski B. M., Gubbins S., Chase-Topping M. E., Schley D., Howey R., Barnett P. V., Gibson D., Juleff N. D., Woolhouse M. E. 2011; Relationship between clinical signs and transmission of an infectious disease and the implications for control. Science 332:726–729 [View Article][PubMed]
    [Google Scholar]
  32. Chinsangaram J., Koster M., Grubman M. J. 2001; Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J Virol 75:5498–5503 [View Article][PubMed]
    [Google Scholar]
  33. Collen T. 1991 T-cell responses of cattle to foot-and-mouth disease virus PhD thesis Council of National Academic Awards; UK:
    [Google Scholar]
  34. Collen T. 1994; Foot and mouth disease (Aphthovirus): viral T cell epitopes. In Cell-Mediated Immunity in Ruminants pp. 173–197 Edited by Goddeevis B. M. L., Morrison W. I. Boca Raton, FL: CRC Press;
    [Google Scholar]
  35. Collen T., Pullen L., Doel T. R. 1989; T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J Gen Virol 70:395–403 [View Article][PubMed]
    [Google Scholar]
  36. Cox S. J., Aggarwal N., Statham R. J., Barnett P. V. 2003; Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 21:1336–1347 [View Article][PubMed]
    [Google Scholar]
  37. Crowther J. R., Farias S., Carpenter W. C., Samuel A. R. 1993; Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J Gen Virol 74:1547–1553 [View Article][PubMed]
    [Google Scholar]
  38. Cunliffe H. R. 1964; Observations on the duration of immunity in cattle after experimental infection with foot-and-mouth disease virus. Cornell Vet 54:501–510[PubMed]
    [Google Scholar]
  39. Cunliffe H. R., Richmond J. Y., Campbell C. H. 1977; Interferon inducers and foot-and-mouth disease vaccines: influence of two synthetic polynucleotides on antibody response and immunity in guinea pigs and swine. Can J Comp Med 41:117–121[PubMed]
    [Google Scholar]
  40. de los Santos T., Diaz-San Segundo F., Grubman M. J. 2007; Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol 81:12803–12815 [View Article][PubMed]
    [Google Scholar]
  41. di Girolamo W., Salas M., Laguens R. P. 1985; Role of Langerhans cells in the infection of the guinea-pig epidermis with foot-and-mouth disease virus. Arch Virol 83:331–336 [View Article][PubMed]
    [Google Scholar]
  42. Dias C. C., Moraes M. P., Segundo F. D., de los Santos T., Grubman M. J. 2011; Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus. J Interferon Cytokine Res 31:227–236 [View Article][PubMed]
    [Google Scholar]
  43. Díaz-San Segundo F., Salguero F. J., de Avila A., Fernandez de Marco M. M., Sánchez-Martín M. A., Sevilla N. 2006; Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J Virol 80:2369–2379 [View Article][PubMed]
    [Google Scholar]
  44. Díaz-San Segundo F., Rodríguez-Calvo T., de Avila A., Sevilla N. 2009; Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10. PLoS ONE 4:e5659 [View Article][PubMed]
    [Google Scholar]
  45. Diaz-San Segundo F., Dias C. C., Moraes M. P., Weiss M., Perez-Martin E., Owens G., Custer M., Kamrud K., de los Santos T., Grubman M. J. 2013; Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus. J Virol 87:5447–5460 [View Article][PubMed]
    [Google Scholar]
  46. Doel T. R. 1996; Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines. Rev Sci Tech 15:883–911[PubMed]
    [Google Scholar]
  47. Doel T. R. 2005; Natural and vaccine induced immunity to FMD. Curr Top Microbiol Immunol 288:103–131[PubMed]
    [Google Scholar]
  48. Donaldson A. I., Ferris N. P., Wells G. A. 1984; Experimental foot-and-mouth disease in fattening pigs, sows and piglets in relation to outbreaks in the field. Vet Rec 115:509–512 [View Article][PubMed]
    [Google Scholar]
  49. Du Y., Bi J., Liu J., Liu X., Wu X., Jiang P., Yoo D., Zhang Y., Wu J. other authors 2014; 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation. J Virol 88:4908–4920 [View Article][PubMed]
    [Google Scholar]
  50. Eblé P. L., Bouma A., Weerdmeester K., Stegeman J. A., Dekker A. 2007; Serological and mucosal immune responses after vaccination and infection with FMDV in pigs. Vaccine 25:1043–1054 [View Article][PubMed]
    [Google Scholar]
  51. Fernández F. M., Borca M. V., Sadir A. M., Fondevila N., Mayo J., Schudel A. A. 1986; Foot-and-mouth disease virus (FMDV) experimental infection: susceptibility and immune response of adult mice. Vet Microbiol 12:15–24 [View Article][PubMed]
    [Google Scholar]
  52. Ferris N. P. 1988; Selection of foot and mouth disease antisera for diagnosis by ELISA. Rev Sci Tech 7:331–346
    [Google Scholar]
  53. Francis M. J., Ouldridge E. J., Black L. 1983; Antibody response in bovine pharyngeal fluid following foot-and-mouth disease vaccination and, or, exposure to live virus. Res Vet Sci 35:206–210[PubMed]
    [Google Scholar]
  54. Francis M. J., Hastings G. Z., Syred A. D., McGinn B., Brown F., Rowlands D. J. 1987; Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature 330:168–170 [View Article][PubMed]
    [Google Scholar]
  55. García-Núñez S., König G., Berinstein A., Carrillo E. 2010; Differences in the virulence of two strains of foot-and-mouth disease virus serotype A with the same spatiotemporal distribution. Virus Res 147:149–152 [View Article][PubMed]
    [Google Scholar]
  56. Garcia-Valcarcel M., Doel T., Collen T., Ryan M., Parkhouse R. M. 1996; Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes. J Gen Virol 77:727–735 [View Article][PubMed]
    [Google Scholar]
  57. Garland A. J. M. 1974 The inhibitory activity of secretions in cattle against foot and mouth disease virus PhD thesis University of London: London, UK;
    [Google Scholar]
  58. Gebauer F., de la Torre J. C., Gomes I., Mateu M. G., Barahona H., Tiraboschi B., Bergmann I., de Mello P. A., Domingo E. 1988; Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J Virol 62:2041–2049[PubMed]
    [Google Scholar]
  59. Ghanem M. M., Abdel-Hamid O. M. 2010; Clinical, haematological and biochemical alterations in heat intolerance (panting) syndrome in Egyptian cattle following natural foot-and-mouth disease (FMD). Trop Anim Health Prod 42:1167–1173 [View Article][PubMed]
    [Google Scholar]
  60. Goldberg R. J., Crowell R. L. 1971; Susceptibility of differentiating muscle cells of the fetal mouse in culture to coxsackievirus A13. J Virol 7:759–769[PubMed]
    [Google Scholar]
  61. Golde W. T., de Los Santos T., Robinson L., Grubman M. J., Sevilla N., Summerfield A., Charleston B. 2011; Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus. Transbound Emerg Dis 58:283–290 [View Article][PubMed]
    [Google Scholar]
  62. Gomes I. 1977; Foot-and-mouth disease: reaction of convalescent pigs to homologous virus exposure. Bol Centr Panam Fiebre Aftosa 26:18–22
    [Google Scholar]
  63. Gomes I., Rosenberg F. J. 1984; A possible role of capybaras (Hydrochoerus hydrochoeris hydrochoeris) in foot-and-mouth disease (FMD) endemicity. Prev Vet Med 3:197–205 [View Article]
    [Google Scholar]
  64. Grubman M. J., Baxt B. 2004; Foot-and-mouth disease. Clin Microbiol Rev 17:465–493 [View Article][PubMed]
    [Google Scholar]
  65. Gulbahar M. Y., Davis W. C., Guvenc T., Yarim M., Parlak U., Kabak Y. B. 2007; Myocarditis associated with foot-and-mouth disease virus type O in lambs. Vet Pathol 44:589–599 [View Article][PubMed]
    [Google Scholar]
  66. Guo H., Liu Z., Sun S., Bao H., Chen Y., Liu X., Xie Q. 2005; Immune response in guinea pigs vaccinated with DNA vaccine of foot-and-mouth disease virus O/China99. Vaccine 23:3236–3242 [View Article][PubMed]
    [Google Scholar]
  67. Guzman E., Taylor G., Charleston B., Skinner M. A., Ellis S. A. 2008; An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J Gen Virol 89:667–675 [View Article][PubMed]
    [Google Scholar]
  68. Guzylack-Piriou L., Bergamin F., Gerber M., McCullough K. C., Summerfield A. 2006; Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur J Immunol 36:1674–1683 [View Article][PubMed]
    [Google Scholar]
  69. Harwood L. J., Gerber H., Sobrino F., Summerfield A., McCullough K. C. 2008; Dendritic cell internalization of foot-and-mouth disease virus: influence of heparan sulfate binding on virus uptake and induction of the immune response. J Virol 82:6379–6394 [View Article][PubMed]
    [Google Scholar]
  70. Hoyler T., Connor C. A., Kiss E. A., Diefenbach A. 2013; T-bet and Gata3 in controlling type 1 and type 2 immunity mediated by innate lymphoid cells. Curr Opin Immunol 25:139–147 [View Article][PubMed]
    [Google Scholar]
  71. Ikehara S., Pahwa R. N., Fernandes G., Hansen C. T., Good R. A. 1984; Functional T cells in athymic nude mice. Proc Natl Acad Sci U S A 81:886–888 [View Article][PubMed]
    [Google Scholar]
  72. Juleff N., Windsor M., Reid E., Seago J., Zhang Z., Monaghan P., Morrison I. W., Charleston B. 2008; Foot-and-mouth disease virus persists in the light zone of germinal centres. PLoS ONE 3:e3434 [View Article][PubMed]
    [Google Scholar]
  73. Juleff N., Windsor M., Lefevre E. A., Gubbins S., Hamblin P., Reid E., McLaughlin K., Beverley P. C., Morrison I. W., Charleston B. 2009; Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle. J Virol 83:3626–3636 [View Article][PubMed]
    [Google Scholar]
  74. Juleff N. D., Maree F. F., Waters R., Bengis R. G., Charleston B. 2012; The importance of FMDV localisation in lymphoid tissue. Vet Immunol Immunopathol 148:145–148 [View Article][PubMed]
    [Google Scholar]
  75. Kamphuis E., Junt T., Waibler Z., Forster R., Kalinke U. 2006; Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood 108:3253–3261 [View Article][PubMed]
    [Google Scholar]
  76. Kamstrup S., Frimann T. H., Barfoed A. M. 2006; Protection of Balb/c mice against infection with FMDV by immunostimulation with CpG oligonucleotides. Antiviral Res 72:42–48 [View Article][PubMed]
    [Google Scholar]
  77. Kitson J. D., McCahon D., Belsham G. J. 1990; Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34 [View Article][PubMed]
    [Google Scholar]
  78. Knudsen R. C., Groocock C. M., Andersen A. A. 1979; Immunity to foot-and-mouth disease virus in guinea pigs: clinical and immune responses. Infect Immun 24:787–792[PubMed]
    [Google Scholar]
  79. Korn G., Potel K. 1954; The lesions of foot and mouth disease in the skeletal muscles of calves. Arch Exp Veterinarmed 8:606–625
    [Google Scholar]
  80. Langellotti C., Quattrocchi V., Alvarez C., Ostrowski M., Gnazzo V., Zamorano P., Vermeulen M. 2012; Foot-and-mouth disease virus causes a decrease in spleen dendritic cells and the early release of IFN-α in the plasma of mice. Differences between infectious and inactivated virus. Antiviral Res 94:62–71 [View Article][PubMed]
    [Google Scholar]
  81. Lefebvre D. J., Neyts J., De Clercq K. 2010; Development of a foot-and-mouth disease infection model in severe combined immunodeficient mice for the preliminary evaluation of antiviral drugs. Transbound Emerg Dis 57:430–433 [View Article][PubMed]
    [Google Scholar]
  82. Loeffler F., Frosch P. 1897; Summarischer Bericht über die Ergebnisse der Untersuchungen der Kommoission zur Erforchung der Maul-und-Klamenseuche. Zentbl Bakteriol Parasitenkd Infektionskr Hyg 22:257–259
    [Google Scholar]
  83. Lombard M., Pastoret P. P., Moulin A. M. 2007; A brief history of vaccines and vaccination. Rev Sci Tech 26:29–48[PubMed]
    [Google Scholar]
  84. López O. J., Sadir A. M., Borca M. V., Fernández F. M., Braun M., Schudel A. A. 1990; Immune response to foot-and-mouth disease virus in an experimental murine model. II. Basis of persistent antibody reaction. Vet Immunol Immunopathol 24:313–321 [View Article][PubMed]
    [Google Scholar]
  85. Machugh N. D., Mburu J. K., Carol M. J., Wyatt C. R., Orden J. A., Davis W. C. 1997; Identification of two distinct subsets of bovine gamma delta T cells with unique cell surface phenotype and tissue distribution. Immunology 92:340–345 [View Article][PubMed]
    [Google Scholar]
  86. Manocchio M. 1974; Selective necrosis of the islets of Langerhans in a cow with experimental foot-and-mouth disease. Veterinaria 50:182
    [Google Scholar]
  87. Mateu M. G., Martínez M. A., Capucci L., Andreu D., Giralt E., Sobrino F., Brocchi E., Domingo E. 1990; A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol 71:629–637 [View Article][PubMed]
    [Google Scholar]
  88. McCullough K. C., De Simone F., Brocchi E., Capucci L., Crowther J. R., Kihm U. 1992; Protective immune response against foot-and-mouth disease. J Virol 66:1835–1840[PubMed]
    [Google Scholar]
  89. McKercher P. D., Giordano A. R. 1967; Foot-and-mouth disease in swine. I. The immune response of swine of chemically-treated and non-treated foot-and-mouth disease virus. Arch Gesamte Virusforsch 20:39–53 [View Article][PubMed]
    [Google Scholar]
  90. Mclaren A., Sanders F. K. 1959; The influence of the age of the host on local virus multiplication and on the resistance to virus infections. J Hyg (Lond) 57:106–122 [View Article][PubMed]
    [Google Scholar]
  91. McVicar J. W., Sutmoller P. 1974; Neutralizing activity in the serum and oesophageal-pharyngeal fluid of cattle after exposure to foot-and-mouth disease virus and subsequent re-exposure. Arch Gesamte Virusforsch 44:173–176 [View Article][PubMed]
    [Google Scholar]
  92. McVicar J. W., Richmond J. Y., Campbell C. H., Hamilton L. D. 1973; Observations of cattle, goats and pigs after administration of synthetic interferon inducers and subsequent exposure to foot and mouth disease virus. Can J Comp Med 37:362–368[PubMed]
    [Google Scholar]
  93. Molinari P., García-Nuñez S., Gravisaco M. J., Carrillo E., Berinstein A., Taboga O. 2010; Baculovirus treatment fully protects mice against a lethal challenge of FMDV. Antiviral Res 87:276–279 [View Article][PubMed]
    [Google Scholar]
  94. Montes C. L., Acosta-Rodríguez E. V., Mucci J., Zuniga E. I., Campetella O., Gruppi A. 2006; A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Eur J Immunol 36:1474–1485 [View Article][PubMed]
    [Google Scholar]
  95. Moraes M. P., Mayr G. A., Mason P. W., Grubman M. J. 2002; Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20:1631–1639 [View Article][PubMed]
    [Google Scholar]
  96. Mosmann T. R., Coffman R. L. 1989; TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173 [View Article][PubMed]
    [Google Scholar]
  97. Naessens J., Scheerlinck J.-P., De Buysscher E. V., Kennedy D., Sileghem M. 1998; Effective in vivo depletion of T cell subpopulations and loss of memory cells in cattle using mouse monoclonal antibodies. Vet Immunol Immunopathol 64:219–234 [View Article][PubMed]
    [Google Scholar]
  98. Nai D. D. 1940; Ricerche sulla istopatologie dei postumi aftosi [Histopathology of complications of foot-and-mouth disease. II. Changes in the organs of internal secretion]. Clin Vet (Milano) 63:205–219 (in Italian)
    [Google Scholar]
  99. Nfon C. K., Ferman G. S., Toka F. N., Gregg D. A., Golde W. T. 2008; Interferon-α production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunol 21:68–77 [View Article][PubMed]
    [Google Scholar]
  100. Nfon C. K., Toka F. N., Kenney M., Pacheco J. M., Golde W. T. 2010; Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection. Viral Immunol 23:29–41 [View Article][PubMed]
    [Google Scholar]
  101. Núñez J. I., Molina N., Baranowski E., Domingo E., Clark S., Burman A., Berryman S., Jackson T., Sobrino F. 2007; Guinea pig-adapted foot-and-mouth disease virus with altered receptor recognition can productively infect a natural host. J Virol 81:8497–8506 [View Article][PubMed]
    [Google Scholar]
  102. OIE 2012 Manual of Diagnostic Tests and Vaccines for Terrestrial Animals chapter 2.1.5, Foot and mouth disease Paris; World Organisation for Animal Health (OIE): http://www.oie.int/international-standard-setting/terrestrial-manual/access-online/
    [Google Scholar]
  103. Ostrowski M., Vermeulen M., Zabal O., Geffner J. R., Sadir A. M., Lopez O. J. 2005; Impairment of thymus-dependent responses by murine dendritic cells infected with foot-and-mouth disease virus. J Immunol 175:3971–3979 [View Article][PubMed]
    [Google Scholar]
  104. Ostrowski M., Vermeulen M., Zabal O., Zamorano P. I., Sadir A. M., Geffner J. R., Lopez O. J. 2007; The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes. J Virol 81:9357–9367 [View Article][PubMed]
    [Google Scholar]
  105. Pacheco J. M., Arzt J., Rodriguez L. L. 2010a; Early events in the pathogenesis of foot-and-mouth disease in cattle after controlled aerosol exposure. Vet J 183:46–53 [View Article][PubMed]
    [Google Scholar]
  106. Pacheco J. M., Butler J. E., Jew J., Ferman G. S., Zhu J., Golde W. T. 2010b; IgA antibody response of swine to foot-and-mouth disease virus infection and vaccination. Clin Vaccine Immunol 17:550–558 [View Article][PubMed]
    [Google Scholar]
  107. Parida S., Anderson J., Cox S. J., Barnett P. V., Paton D. J. 2006; Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance. Vaccine 24:1107–1116 [View Article][PubMed]
    [Google Scholar]
  108. Pega J., Bucafusco D., Di Giacomo S., Schammas J. M., Malacari D., Capozzo A. V., Arzt J., Pérez-Beascoechea C., Maradei E. other authors 2013; Early adaptive immune responses in the respiratory tract of foot-and-mouth disease virus-infected cattle. J Virol 87:2489–2495 [View Article][PubMed]
    [Google Scholar]
  109. Pérez Filgueira D. M., Berinstein A., Smitsaart E., Borca M. V., Sadir A. M. 1995; Isotype profiles induced in Balb/c mice during foot and mouth disease (FMD) virus infection or immunization with different FMD vaccine formulations. Vaccine 13:953–960 [View Article][PubMed]
    [Google Scholar]
  110. Perez-Martin E., Weiss M., Diaz-San Segundo F., Pacheco J. M., Arzt J., Grubman M. J., de los Santos T. 2012; Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle. J Virol 86:4477–4487 [View Article][PubMed]
    [Google Scholar]
  111. Perez-Martin E., Diaz-San Segundo F., Weiss M., Sturza D. F., Dias C. C., Ramirez-Medina E., Grubman M. J., de Los Santos T. 2014; Type III interferon protects swine against foot-and-mouth disease. J Interferon Cytokine Res10.1089/jir.2013.0112 [Epub ahead of print] [View Article][PubMed]
    [Google Scholar]
  112. Pestka S., Krause C. D., Sarkar D., Walter M. R., Shi Y., Fisher P. B. 2004; Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22:929–979 [View Article][PubMed]
    [Google Scholar]
  113. Piatti P. G., Berinstein A., Lopez O. J., Borca M. V., Fernandez F., Schudel A. A., Sadir A. M. 1991; Comparison of the immune response elicited by infectious and inactivated foot-and-mouth disease virus in mice. J Gen Virol 72:1691–1694 [View Article][PubMed]
    [Google Scholar]
  114. Platt H. 1956; A study of the pathological changes produced in young mice by the virus of foot-and-mouth disease. J Pathol Bacteriol 72:299–312 [View Article][PubMed]
    [Google Scholar]
  115. Reid E., Juleff N., Gubbins S., Prentice H., Seago J., Charleston B. 2011; Bovine plasmacytoid dendritic cells are the major source of type I interferon in response to foot-and-mouth disease virus in vitro and in vivo . J Virol 85:4297–4308 [View Article][PubMed]
    [Google Scholar]
  116. Richmond J. Y., Hamilton L. D. 1969; Foot-and-mouth disease virus inhibition induced in mice by synthetic double-stranded RNA (polyriboinosinic and polyribocytidylic acids). Proc Natl Acad Sci U S A 64:81–86 [View Article][PubMed]
    [Google Scholar]
  117. Rigden R. C., Carrasco C. P., Summerfield A., MCCullough K. C. 2002; Macrophage phagocytosis of foot-and-mouth disease virus may create infectious carriers. Immunology 106:537–548 [View Article][PubMed]
    [Google Scholar]
  118. Robinson L., Windsor M., McLaughlin K., Hope J., Jackson T., Charleston B. 2011; Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells. J Virol 85:2212–2223 [View Article][PubMed]
    [Google Scholar]
  119. Rodriguez L. L., Barrera J., Kramer E., Lubroth J., Brown F., Golde W. T. 2003; A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21:3751–3756 [View Article][PubMed]
    [Google Scholar]
  120. Rodríguez-Pulido M., Borrego B., Sobrino F., Sáiz M. 2011a; RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice. J Virol 85:6492–6501 [View Article][PubMed]
    [Google Scholar]
  121. Rodríguez-Pulido M., Sobrino F., Borrego B., Sáiz M. 2011b; Inoculation of newborn mice with non-coding regions of foot-and-mouth disease virus RNA can induce a rapid, solid and wide-range protection against viral infection. Antiviral Res 92:500–504 [View Article][PubMed]
    [Google Scholar]
  122. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypiä T. 1994; Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 203:357–365 [View Article][PubMed]
    [Google Scholar]
  123. Salguero F. J., Sánchez-Martín M. A., Díaz-San Segundo F., de Avila A., Sevilla N. 2005; Foot-and-mouth disease virus (FMDV) causes an acute disease that can be lethal for adult laboratory mice. Virology 332:384–396 [View Article][PubMed]
    [Google Scholar]
  124. Salt J. S., Mulcahy G., Kitching R. P. 1996; Isotype-specific antibody responses to foot-and-mouth disease virus in sera and secretions of “carrier’ and “non-carrier’ cattle. Epidemiol Infect 117:349–360 [View Article][PubMed]
    [Google Scholar]
  125. Sanyal A., Venkataramanan R., Pattnaik B. 1997; Antigenic features of foot-and-mouth disease virus serotype Asia1 as revealed by monoclonal antibodies and neutralization-escape mutants. Virus Res 50:107–117 [View Article][PubMed]
    [Google Scholar]
  126. Sanz-Ramos M., Díaz-San Segundo F., Escarmís C., Domingo E., Sevilla N. 2008; Hidden virulence determinants in a viral quasispecies in vivo . J Virol 82:10465–10476 [View Article][PubMed]
    [Google Scholar]
  127. Shimshony A., Orgad U., Baharav D., Prudovsky S., Yakobson B., Bar Moshe B., Dagan D. 1986; Malignant foot-and-mouth disease in mountain gazelles. Vet Rec 119:175–176 [View Article][PubMed]
    [Google Scholar]
  128. Skinner H. H. 1951; Propagation of strains of foot-and-mouth disease virus in unweaned white mice. Proc R Soc Med 44:1041–1044[PubMed]
    [Google Scholar]
  129. Skinner H. H. 1954; Infection of chickens and chick embryos with the viruses of foot-and-mouth disease and of vesicular stomatitis. Nature 174:1052–1053 [View Article][PubMed]
    [Google Scholar]
  130. Skinner H. H., Henderson W. M., Brooksby J. B. 1952; Use of unweaned white mice in foot-and-mouth disease research. Nature 169:794–795 [View Article][PubMed]
    [Google Scholar]
  131. Subak-Sharpe H., Pringle C. R., Hollom S. E. 1963; Factors influencing the dynamics of the multiplication of foot-and-mouth disease virus in adult mice. Arch Gesamte Virusforsch 12:600–619 [View Article][PubMed]
    [Google Scholar]
  132. Summerfield A., Guzylack-Piriou L., Harwood L., McCullough K. C. 2009; Innate immune responses against foot-and-mouth disease virus: current understanding and future directions. Vet Immunol Immunopathol 128:205–210 [View Article][PubMed]
    [Google Scholar]
  133. Swanson C. L., Wilson T. J., Strauch P., Colonna M., Pelanda R., Torres R. M. 2010; Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J Exp Med 207:1485–1500 [View Article][PubMed]
    [Google Scholar]
  134. Taboga O., Tami C., Carrillo E., Núñez J. I., Rodríguez A., Saíz J. C., Blanco E., Valero M. L., Roig X. other authors 1997; A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol 71:2606–2614[PubMed]
    [Google Scholar]
  135. Takamatsu H. H., Denyer M. S., Stirling C., Cox S., Aggarwal N., Dash P., Wileman T. E., Barnett P. V. 2006; Porcine γδ T cells: possible roles on the innate and adaptive immune responses following virus infection. Vet Immunol Immunopathol 112:49–61 [View Article][PubMed]
    [Google Scholar]
  136. Talbot P. J., Buchmeier M. J. 1987; Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice. Immunology 60:485–489[PubMed]
    [Google Scholar]
  137. van der Poel C. E., Spaapen R. M., van de Winkel J. G., Leusen J. H. 2011; Functional characteristics of the high affinity IgG receptor, FcγRI. J Immunol 186:2699–2704 [View Article][PubMed]
    [Google Scholar]
  138. Vieira P., Rajewsky K. 1988; The half-lives of serum immunoglobulins in adult mice. Eur J Immunol 18:313–316 [View Article][PubMed]
    [Google Scholar]
  139. Waldman O., Pape J. 1920; Die künstliche Übertragung der Maul-und Klauenseuche auf das Meerschweinchen. Berl Munch Tierarztl Wochenschr 36:519–520
    [Google Scholar]
  140. Wang C. Y., Chang T. Y., Walfield A. M., Ye J., Shen M., Chen S. P., Li M. C., Lin Y. L., Jong M. H. other authors 2002; Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20:2603–2610 [View Article][PubMed]
    [Google Scholar]
  141. Wang D., Fang L., Luo R., Ye R., Fang Y., Xie L., Chen H., Xiao S. 2010; Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem Biophys Res Commun 399:72–78 [View Article][PubMed]
    [Google Scholar]
  142. Wang D., Fang L., Li K., Zhong H., Fan J., Ouyang C., Zhang H., Duan E., Luo R. other authors 2012; Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J Virol 86:9311–9322 [View Article][PubMed]
    [Google Scholar]
  143. Wang F., Ekiert D. C., Ahmad I., Yu W., Zhang Y., Bazirgan O., Torkamani A., Raudsepp T., Mwangi W. other authors 2013; Reshaping antibody diversity. Cell 153:1379–1393 [View Article][PubMed]
    [Google Scholar]
  144. Wigdorovitz A., Zamorano P., Fernández F. M., López O., Prato-Murphy M., Carrillo C., Sadir A. M., Borca M. V. 1997; Duration of the foot-and-mouth disease virus antibody response in mice is closely related to the presence of antigen-specific presenting cells. J Gen Virol 78:1025–1032[PubMed]
    [Google Scholar]
  145. Windsor M. A., Carr B. V., Bankowski B., Gibson D., Reid E., Hamblin P., Gubbins S., Juleff N., Charleston B. 2011; Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection. Vet Res 42:108 [View Article][PubMed]
    [Google Scholar]
  146. Wrammert J., Ahmed R. 2008; Maintenance of serological memory. Biol Chem 389:537–539 [View Article][PubMed]
    [Google Scholar]
  147. Yang B., Lan X., Li X., Yin X., Li B., Han X., Li Y., Zhang Z., Liu J. 2008; A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5′UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice. Vaccine 26:5477–5483 [View Article][PubMed]
    [Google Scholar]
  148. Yao Q., Qian P., Huang Q., Cao Y., Chen H. 2008; Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs. J Virol Methods 147:143–150 [View Article][PubMed]
    [Google Scholar]
  149. Yeotikar P. V., Bapat S. T., Bilolikar S. C., Kulkarni S. S. 2003; Metabolic profile of healthy cattle and cattle affected by foot-and-mouth disease. Vet Rec 153:19–20 [View Article][PubMed]
    [Google Scholar]
  150. Zabel F., Kündig T. M., Bachmann M. F. 2013; Virus-induced humoral immunity: on how B cell responses are initiated. Curr Opin Virol 3:357–362 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.068270-0
Loading
/content/journal/jgv/10.1099/vir.0.068270-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error